Clinical Trial Update: To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids [Phase 3]

View source ↗

Summary

A Phase 3 trial update protocol comparing addition of methotrexate to standard corticosteroid-first-line treatment for acute graft-versus-host disease (GVHD) in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allogeneic Stem Cell Transplantation Complications
• Graft-versus-host Disease

Drugs mentioned

• Corticosteroids (corticosteroids)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Allogeneic Disease, GVH - Graft Versus Host Reaction | Phase 3 | Status: UNKNOWN